Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2009

Open Access 01-12-2009 | Study protocol

Prediction and treatment of asthma in preschool children at risk: study design and baseline data of a prospective cohort study in general practice (ARCADE)

Authors: Karina E van Wonderen, Lonneke B van der Mark, Jacob Mohrs, Ronald B Geskus, Willem M van der Wal, Wim MC van Aalderen, Patrick JE Bindels, Gerben ter Riet

Published in: BMC Pulmonary Medicine | Issue 1/2009

Login to get access

Abstract

Background

Asthma is a difficult diagnosis to establish in preschool children. A few years ago, our group presented a prediction rule for young children at risk for asthma in general practice. Before this prediction rule can safely be used in practice, cross-validation is required. In addition, general practitioners face many therapeutic management decisions in children at risk for asthma. The objectives of the study are: (1) identification of predictors for asthma in preschool children at risk for asthma with the aim of cross-validating an earlier derived prediction rule; (2) compare the effects of different treatment strategies in preschool children.

Design

In this prospective cohort study one to five year old children at risk of developing asthma were selected from general practices. At risk was defined as 'visited the general practitioner with recurrent coughing (≥ 2 visits), wheezing (≥ 1) or shortness of breath (≥ 1) in the previous 12 months'. All children in this prospective cohort study will be followed until the age of six. For our prediction rule, demographic data, data with respect to clinical history and additional tests (specific immunoglobulin E (IgE), fractional exhaled nitric oxide (FENO), peak expiratory flow (PEF)) are collected. History of airway specific medication use, symptom severity and health-related quality of life (QoL) are collected to estimate the effect of different treatment intensities (as expressed in GINA levels) using recently developed statistical techniques. In total, 1,938 children at risk of asthma were selected from general practice and 771 children (40%) were enrolled. At the time of writing, follow-up for all 5-year olds and the majority of the 4-year olds is complete. The total and specific IgE measurements at baseline were carried out by 87% of the children. Response rates to the repeated questionnaires varied from 93% at baseline to 73% after 18 months follow-up; 89% and 87% performed PEF and FENO measurements, respectively.

Discussion

In this study a prediction rule for asthma in young children, to be used in (general) practice, will be cross-validated. Our study will also provide more insight in the effect of treatment of asthma in preschool children.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Tattersfield AE, Knox AJ, Britton JR, Hall IP: Asthma. The Lancet. 2002, 360: 1313-1322. 10.1016/S0140-6736(02)11312-2.CrossRef Tattersfield AE, Knox AJ, Britton JR, Hall IP: Asthma. The Lancet. 2002, 360: 1313-1322. 10.1016/S0140-6736(02)11312-2.CrossRef
3.
go back to reference Sporik R, Holgate ST, Platts-Mills TA, Cogswell JJ: Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. N Engl J Med. 1990, 323: 502-507.CrossRefPubMed Sporik R, Holgate ST, Platts-Mills TA, Cogswell JJ: Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. N Engl J Med. 1990, 323: 502-507.CrossRefPubMed
4.
go back to reference Celedón JC, Litonjua AA, Ryan L, Platts-Mills T, Weiss ST, Gold DR: Exposure to cat allergen, maternal history of asthma, and wheezing in first 5 years of life. Lancet. 2002, 360: 781-782. 10.1016/S0140-6736(02)09906-3.CrossRefPubMed Celedón JC, Litonjua AA, Ryan L, Platts-Mills T, Weiss ST, Gold DR: Exposure to cat allergen, maternal history of asthma, and wheezing in first 5 years of life. Lancet. 2002, 360: 781-782. 10.1016/S0140-6736(02)09906-3.CrossRefPubMed
5.
go back to reference Melén E, Wickman M, Nordvall SL, van Hage-Hamsten M, Lindfors A: Influence of early and current environmental exposure factors on sensitization and outcome of asthma in pre-school children. Allergy. 2001, 56: 646-652. 10.1034/j.1398-9995.2001.00387.x.CrossRefPubMed Melén E, Wickman M, Nordvall SL, van Hage-Hamsten M, Lindfors A: Influence of early and current environmental exposure factors on sensitization and outcome of asthma in pre-school children. Allergy. 2001, 56: 646-652. 10.1034/j.1398-9995.2001.00387.x.CrossRefPubMed
6.
go back to reference Almqvist C, Egmar AC, van Hage-Hamsten M, Berglind N, Pershagen G, Nordvall SL, et al: Heredity, pet ownership, and confounding control in a population-based birth cohort. J Allergy Clin Immunol. 2003, 111 (4): 800-806. 10.1067/mai.2003.1334.CrossRefPubMed Almqvist C, Egmar AC, van Hage-Hamsten M, Berglind N, Pershagen G, Nordvall SL, et al: Heredity, pet ownership, and confounding control in a population-based birth cohort. J Allergy Clin Immunol. 2003, 111 (4): 800-806. 10.1067/mai.2003.1334.CrossRefPubMed
7.
go back to reference Strachan DP, Cook DG: Health effects of passive smoking. 6. Parental smoking and childhood asthma: longitudinal and case-control studies. Thorax. 1998, 53: 204-212.CrossRefPubMedPubMedCentral Strachan DP, Cook DG: Health effects of passive smoking. 6. Parental smoking and childhood asthma: longitudinal and case-control studies. Thorax. 1998, 53: 204-212.CrossRefPubMedPubMedCentral
8.
go back to reference Dezateux C, Stocks J, Dunas I, Fletcher ME: Impaired Airway Function and Wheezing in Infancy. The Influence of Maternal Smoking and a Genetic Predisposition to Asthma. Am J Respir Crit Care Med. 1999, 159 (2): 403-410.CrossRefPubMed Dezateux C, Stocks J, Dunas I, Fletcher ME: Impaired Airway Function and Wheezing in Infancy. The Influence of Maternal Smoking and a Genetic Predisposition to Asthma. Am J Respir Crit Care Med. 1999, 159 (2): 403-410.CrossRefPubMed
9.
go back to reference Gern JE, Busse WW: Relationship of viral infections to wheezing illnesses and asthma. Nat Rev Immunol. 2002, 2: 132-138. 10.1038/nri725.CrossRefPubMed Gern JE, Busse WW: Relationship of viral infections to wheezing illnesses and asthma. Nat Rev Immunol. 2002, 2: 132-138. 10.1038/nri725.CrossRefPubMed
10.
go back to reference Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B: Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med. 2000, 161: 1501-1507.CrossRefPubMed Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B: Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med. 2000, 161: 1501-1507.CrossRefPubMed
11.
go back to reference Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, et al: Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 1999, 354: 541-545. 10.1016/S0140-6736(98)10321-5.CrossRefPubMed Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, et al: Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 1999, 354: 541-545. 10.1016/S0140-6736(98)10321-5.CrossRefPubMed
12.
go back to reference Friedman NJ, Zeiger RS: The role of breast-feeding in the development of allergies and asthma. Journal of Allergy and Clinical Immunology. 2005, 115: 1238-1248. 10.1016/j.jaci.2005.01.069.CrossRefPubMed Friedman NJ, Zeiger RS: The role of breast-feeding in the development of allergies and asthma. Journal of Allergy and Clinical Immunology. 2005, 115: 1238-1248. 10.1016/j.jaci.2005.01.069.CrossRefPubMed
13.
go back to reference Horwood LJ, Fergusson DM, Shannon FT: Social and Familial Factors in the Development of Early Childhood Asthma. Pediatrics. 1985, 75: 859-868.PubMed Horwood LJ, Fergusson DM, Shannon FT: Social and Familial Factors in the Development of Early Childhood Asthma. Pediatrics. 1985, 75: 859-868.PubMed
14.
go back to reference Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ: Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med. 1995, 332: 133-138. 10.1056/NEJM199501193320301.CrossRefPubMed Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ: Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med. 1995, 332: 133-138. 10.1056/NEJM199501193320301.CrossRefPubMed
15.
go back to reference Beuther DA, Weiss ST, Sutherland ER: Obesity and Asthma. American Journal of Respiratory and Critical Care Medicine. 2006, 174: 112-119. 10.1164/rccm.200602-231PP.CrossRefPubMedPubMedCentral Beuther DA, Weiss ST, Sutherland ER: Obesity and Asthma. American Journal of Respiratory and Critical Care Medicine. 2006, 174: 112-119. 10.1164/rccm.200602-231PP.CrossRefPubMedPubMedCentral
16.
go back to reference Shore SA, Fredberg JJ: Obesity, smooth muscle, and airway hyperresponsiveness. Journal of Allergy and Clinical Immunology. 2005, 115: 925-927. 10.1016/j.jaci.2005.01.064.CrossRefPubMed Shore SA, Fredberg JJ: Obesity, smooth muscle, and airway hyperresponsiveness. Journal of Allergy and Clinical Immunology. 2005, 115: 925-927. 10.1016/j.jaci.2005.01.064.CrossRefPubMed
17.
go back to reference Bisgaard H, Allen D, Milanowski J, Kalev I, Willits L, Davies P: Twelve-Month Safety and Efficacy of Inhaled Fluticasone Propionate in Children Aged 1 to 3 Years With Recurrent Wheezing. Pediatrics. 2004, 113: e87-e94. 10.1542/peds.113.2.e87.CrossRefPubMed Bisgaard H, Allen D, Milanowski J, Kalev I, Willits L, Davies P: Twelve-Month Safety and Efficacy of Inhaled Fluticasone Propionate in Children Aged 1 to 3 Years With Recurrent Wheezing. Pediatrics. 2004, 113: e87-e94. 10.1542/peds.113.2.e87.CrossRefPubMed
18.
go back to reference Pao CS, McKenzie SA: Randomized Controlled Trial of Fluticasone in Preschool Children with Intermittent Wheeze. American Journal of Respiratory and Critical Care Medicine . 2002, 166 (7): 945-949. 10.1164/rccm.200203-265OC.CrossRefPubMed Pao CS, McKenzie SA: Randomized Controlled Trial of Fluticasone in Preschool Children with Intermittent Wheeze. American Journal of Respiratory and Critical Care Medicine . 2002, 166 (7): 945-949. 10.1164/rccm.200203-265OC.CrossRefPubMed
19.
go back to reference Roorda RJ, Mezei G, Bisgaard H, Maden C: Response of preschool children with asthma symptoms to fluticasone propionate. J Allergy Clin Immunol. 2001, 108: 540-546. 10.1067/mai.2001.118789.CrossRefPubMed Roorda RJ, Mezei G, Bisgaard H, Maden C: Response of preschool children with asthma symptoms to fluticasone propionate. J Allergy Clin Immunol. 2001, 108: 540-546. 10.1067/mai.2001.118789.CrossRefPubMed
20.
go back to reference Teper AM, Kofman CD, Szulman GA, Vidaurreta SM, Maffey AF: Fluticasone Improves Pulmonary Function in Children under 2 Years Old with Risk Factors for Asthma. American Journal of Respiratory and Critical Care Medicine . 2005, 171 (6): 587-590. 10.1164/rccm.200408-1088OC.CrossRefPubMed Teper AM, Kofman CD, Szulman GA, Vidaurreta SM, Maffey AF: Fluticasone Improves Pulmonary Function in Children under 2 Years Old with Risk Factors for Asthma. American Journal of Respiratory and Critical Care Medicine . 2005, 171 (6): 587-590. 10.1164/rccm.200408-1088OC.CrossRefPubMed
21.
go back to reference Balemans WA, van der Ent CK, Schilder AG, Sanders EA, Zielhuis GA, Rovers MM: Prediction of asthma in young adults using childhood characteristics: Development of a prediction rule. J Clin Epidemiol . 2006, 59 (11): 1207-1212. 10.1016/j.jclinepi.2006.02.011.CrossRefPubMed Balemans WA, van der Ent CK, Schilder AG, Sanders EA, Zielhuis GA, Rovers MM: Prediction of asthma in young adults using childhood characteristics: Development of a prediction rule. J Clin Epidemiol . 2006, 59 (11): 1207-1212. 10.1016/j.jclinepi.2006.02.011.CrossRefPubMed
22.
go back to reference Castro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD: A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med. 2000, 162: 1403-1406.CrossRefPubMed Castro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD: A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med. 2000, 162: 1403-1406.CrossRefPubMed
23.
go back to reference Eysink PE, ter Riet G, Aalberse RC, van Aalderen WM, Roos CM, van der Zee JS, et al: Accuracy of specific IgE in the prediction of asthma: development of a scoring formula for general practice. Br J Gen Pract. 2005, 55: 125-131.PubMedPubMedCentral Eysink PE, ter Riet G, Aalberse RC, van Aalderen WM, Roos CM, van der Zee JS, et al: Accuracy of specific IgE in the prediction of asthma: development of a scoring formula for general practice. Br J Gen Pract. 2005, 55: 125-131.PubMedPubMedCentral
24.
go back to reference Steyerberg EW, Borsboom GJ, van Houwelingen HC, Eijkemans MJ, Habbema JD: Validation and updating of predictive logistic regression models: a study on sample size and shrinkage. Statistics in Medicine. 2004, 23 (16): 2567-2586. 10.1002/sim.1844.CrossRefPubMed Steyerberg EW, Borsboom GJ, van Houwelingen HC, Eijkemans MJ, Habbema JD: Validation and updating of predictive logistic regression models: a study on sample size and shrinkage. Statistics in Medicine. 2004, 23 (16): 2567-2586. 10.1002/sim.1844.CrossRefPubMed
25.
go back to reference NHBLI/WHO Workshop Report: Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma. Revised 2007. 2007, National Institutes of Health and National Heart, Lung and Blood Institute. NIH Publication No 02-3659, Ref Type: Report NHBLI/WHO Workshop Report: Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma. Revised 2007. 2007, National Institutes of Health and National Heart, Lung and Blood Institute. NIH Publication No 02-3659, Ref Type: Report
26.
go back to reference Steyerberg EW, Bleeker SE, Moll HA, Grobbee DE, Moons KG: Internal and external validation of predictive models: A simulation study of bias and precision in small samples. J Clin Epidemiol. 2003, 56: 441-447. 10.1016/S0895-4356(03)00047-7.CrossRefPubMed Steyerberg EW, Bleeker SE, Moll HA, Grobbee DE, Moons KG: Internal and external validation of predictive models: A simulation study of bias and precision in small samples. J Clin Epidemiol. 2003, 56: 441-447. 10.1016/S0895-4356(03)00047-7.CrossRefPubMed
27.
go back to reference Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F, et al: International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J. 1995, 8: 483-491. 10.1183/09031936.95.08030483.CrossRefPubMed Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F, et al: International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J. 1995, 8: 483-491. 10.1183/09031936.95.08030483.CrossRefPubMed
28.
go back to reference Stapel SO, Eysink PED, de Vrieze J, Aalberse RC: IgE testing in capillary blood. Pediatric Allergy and Immunology . 2004, 15 (3): 230-233. 10.1111/j.1399-3038.2004.00142.x.CrossRefPubMed Stapel SO, Eysink PED, de Vrieze J, Aalberse RC: IgE testing in capillary blood. Pediatric Allergy and Immunology . 2004, 15 (3): 230-233. 10.1111/j.1399-3038.2004.00142.x.CrossRefPubMed
29.
go back to reference Pijnenburg MW, Lissenberg ET, Hofhuis W, Ghiro L, Hop WCJ, Holland WP, et al: Exhaled nitric oxide measurements with dynamic flow restriction in children aged 4–8 yrs. Eur Respir J. 2002, 20 (4): 919-924. 10.1183/09031936.02.01282002.CrossRefPubMed Pijnenburg MW, Lissenberg ET, Hofhuis W, Ghiro L, Hop WCJ, Holland WP, et al: Exhaled nitric oxide measurements with dynamic flow restriction in children aged 4–8 yrs. Eur Respir J. 2002, 20 (4): 919-924. 10.1183/09031936.02.01282002.CrossRefPubMed
31.
go back to reference Cockcroft DW: Bronchoprovocation methods – Direct challenges. Clinical Reviews in Allergy & Immunology. 2003, 24: 19-26. 10.1385/CRIAI:24:1:19.CrossRef Cockcroft DW: Bronchoprovocation methods – Direct challenges. Clinical Reviews in Allergy & Immunology. 2003, 24: 19-26. 10.1385/CRIAI:24:1:19.CrossRef
32.
go back to reference Cockcroft DW, Killian DN, Mellon JJ, Hargreave FE: Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy. 1977, 7: 235-243. 10.1111/j.1365-2222.1977.tb01448.x.CrossRefPubMed Cockcroft DW, Killian DN, Mellon JJ, Hargreave FE: Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy. 1977, 7: 235-243. 10.1111/j.1365-2222.1977.tb01448.x.CrossRefPubMed
33.
go back to reference Harrell FE: Regression modelling strategies. With applications to linear models, logistic regression and survival analysis. New York Springer, 1 A.D Harrell FE: Regression modelling strategies. With applications to linear models, logistic regression and survival analysis. New York Springer, 1 A.D
35.
go back to reference Sauerbrei W, Schumacher M: A Bootstrap Resampling Procedure for Model-Building – Application to the Cox Regression-Model. Statistics in Medicine. 1992, 11: 2093-2109. 10.1002/sim.4780111607.CrossRefPubMed Sauerbrei W, Schumacher M: A Bootstrap Resampling Procedure for Model-Building – Application to the Cox Regression-Model. Statistics in Medicine. 1992, 11: 2093-2109. 10.1002/sim.4780111607.CrossRefPubMed
36.
go back to reference Harrell FE, Lee KL, Mark DB: Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statistics in Medicine. 1996, 15: 361-387. 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4.CrossRefPubMed Harrell FE, Lee KL, Mark DB: Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statistics in Medicine. 1996, 15: 361-387. 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4.CrossRefPubMed
37.
go back to reference Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M: Measuring quality of life in children with asthma. Qual Life Res. 1996, 5: 35-46. 10.1007/BF00435967.CrossRefPubMed Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M: Measuring quality of life in children with asthma. Qual Life Res. 1996, 5: 35-46. 10.1007/BF00435967.CrossRefPubMed
38.
go back to reference Raat H, Bonsel GJ, Essink-Bot ML, Landgraf JM, Gemke RJBJ: Reliability and validity of comprehensive health status measures in children: The Child Health Questionnaire in relation to the Health Utilities Index. J Clin Epidemiol. 2002, 55: 67-76. 10.1016/S0895-4356(01)00411-5.CrossRefPubMed Raat H, Bonsel GJ, Essink-Bot ML, Landgraf JM, Gemke RJBJ: Reliability and validity of comprehensive health status measures in children: The Child Health Questionnaire in relation to the Health Utilities Index. J Clin Epidemiol. 2002, 55: 67-76. 10.1016/S0895-4356(01)00411-5.CrossRefPubMed
39.
go back to reference Robins JM, Hernan MA, Brumback B: Marginal structural models and causal inference in epidemiology. Epidemiology. 2000, 11: 550-560. 10.1097/00001648-200009000-00011.CrossRefPubMed Robins JM, Hernan MA, Brumback B: Marginal structural models and causal inference in epidemiology. Epidemiology. 2000, 11: 550-560. 10.1097/00001648-200009000-00011.CrossRefPubMed
40.
go back to reference Choi HK, Hernan MA, Seeger JD, Robins JM, Wolfe F: Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet. 2002, 359: 1173-1177. 10.1016/S0140-6736(02)08213-2.CrossRefPubMed Choi HK, Hernan MA, Seeger JD, Robins JM, Wolfe F: Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet. 2002, 359: 1173-1177. 10.1016/S0140-6736(02)08213-2.CrossRefPubMed
41.
go back to reference Cole SR, Hernan MA, Robins JM, Anastos K, Chmiel J, Detels R, et al: Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. Am J Epidemiol. 2003, 158: 687-694. 10.1093/aje/kwg206.CrossRefPubMed Cole SR, Hernan MA, Robins JM, Anastos K, Chmiel J, Detels R, et al: Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. Am J Epidemiol. 2003, 158: 687-694. 10.1093/aje/kwg206.CrossRefPubMed
42.
go back to reference Cole SR, Hernan MA, Margolick JB, Cohen MH, Robins JM: Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell count. Am J Epidemiol. 2005, 162: 471-478. 10.1093/aje/kwi216.CrossRefPubMed Cole SR, Hernan MA, Margolick JB, Cohen MH, Robins JM: Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell count. Am J Epidemiol. 2005, 162: 471-478. 10.1093/aje/kwi216.CrossRefPubMed
43.
go back to reference Cole SR, Hernan MA, Anastos K, Jamieson BD, Robins JM: Determining the effect of highly active antiretroviral therapy on changes in human immunodeficiency virus type 1 RNA viral load using a marginal structural left-censored mean model. Am J Epidemiol. 2007, 166: 219-227. 10.1093/aje/kwm047.CrossRefPubMed Cole SR, Hernan MA, Anastos K, Jamieson BD, Robins JM: Determining the effect of highly active antiretroviral therapy on changes in human immunodeficiency virus type 1 RNA viral load using a marginal structural left-censored mean model. Am J Epidemiol. 2007, 166: 219-227. 10.1093/aje/kwm047.CrossRefPubMed
44.
go back to reference Hernan MA, Brumback B, Robins JM: Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology. 2000, 11: 561-570. 10.1097/00001648-200009000-00012.CrossRefPubMed Hernan MA, Brumback B, Robins JM: Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology. 2000, 11: 561-570. 10.1097/00001648-200009000-00012.CrossRefPubMed
45.
go back to reference Hernan MA, Brumback BA, Robins JM: Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures. Statistics in Medicine. 2002, 21: 1689-1709. 10.1002/sim.1144.CrossRefPubMed Hernan MA, Brumback BA, Robins JM: Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures. Statistics in Medicine. 2002, 21: 1689-1709. 10.1002/sim.1144.CrossRefPubMed
46.
go back to reference Hernan MA, Hernandez-Diaz S, Robins JM: A structural approach to selection bias. Epidemiology. 2004, 15: 615-625. 10.1097/01.ede.0000135174.63482.43.CrossRefPubMed Hernan MA, Hernandez-Diaz S, Robins JM: A structural approach to selection bias. Epidemiology. 2004, 15: 615-625. 10.1097/01.ede.0000135174.63482.43.CrossRefPubMed
47.
go back to reference Hernan MA, Robins JM: Instruments for causal inference – An epidemiologist's dream?. Epidemiology. 2006, 17: 360-372. 10.1097/01.ede.0000222409.00878.37.CrossRefPubMed Hernan MA, Robins JM: Instruments for causal inference – An epidemiologist's dream?. Epidemiology. 2006, 17: 360-372. 10.1097/01.ede.0000222409.00878.37.CrossRefPubMed
48.
49.
go back to reference Sterne JA, Hernan MA, Ledergerber B, Tilling K, Weber R, Sendi P, et al: Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet. 2005, 366: 378-384. 10.1016/S0140-6736(05)67022-5.CrossRefPubMed Sterne JA, Hernan MA, Ledergerber B, Tilling K, Weber R, Sendi P, et al: Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet. 2005, 366: 378-384. 10.1016/S0140-6736(05)67022-5.CrossRefPubMed
50.
go back to reference Lavori PW, Dawson R: Dynamic treatment regimes: practical design considerations. Clinical Trials. 2004, 1: 9-20. 10.1191/1740774S04cn002oa.CrossRefPubMed Lavori PW, Dawson R: Dynamic treatment regimes: practical design considerations. Clinical Trials. 2004, 1: 9-20. 10.1191/1740774S04cn002oa.CrossRefPubMed
51.
go back to reference Moodie EE, Richardson TS, Stephens DA: Demystifying optimal dynamic treatment regimes. Biometrics. 2007, 63: 447-455. 10.1111/j.1541-0420.2006.00686.x.CrossRefPubMed Moodie EE, Richardson TS, Stephens DA: Demystifying optimal dynamic treatment regimes. Biometrics. 2007, 63: 447-455. 10.1111/j.1541-0420.2006.00686.x.CrossRefPubMed
52.
go back to reference Murphy SA: Optimal dynamic treatment regimes. Journal of the Royal Statistical Society Series B-Statistical Methodology. 2003, 65: 331-355. 10.1111/1467-9868.00389.CrossRef Murphy SA: Optimal dynamic treatment regimes. Journal of the Royal Statistical Society Series B-Statistical Methodology. 2003, 65: 331-355. 10.1111/1467-9868.00389.CrossRef
53.
go back to reference Rosthoj S, Fullwood C, Henderson R, Stewart S: Estimation of optimal dynamic anticoagulation regimes from observational data: A regret-based approach. Statistics in Medicine. 2006, 25: 4197-4215. 10.1002/sim.2694.CrossRefPubMed Rosthoj S, Fullwood C, Henderson R, Stewart S: Estimation of optimal dynamic anticoagulation regimes from observational data: A regret-based approach. Statistics in Medicine. 2006, 25: 4197-4215. 10.1002/sim.2694.CrossRefPubMed
54.
go back to reference Chen W, Purohit A, Barnig C, Casset A, de Blay F: Niox (R) and Niox Mino (R): comparison of exhaled NO in grass pollen allergic adult volunteers. Allergy. 2007, 62: 571-572. 10.1111/j.1398-9995.2007.01334.x.CrossRefPubMed Chen W, Purohit A, Barnig C, Casset A, de Blay F: Niox (R) and Niox Mino (R): comparison of exhaled NO in grass pollen allergic adult volunteers. Allergy. 2007, 62: 571-572. 10.1111/j.1398-9995.2007.01334.x.CrossRefPubMed
55.
go back to reference Bisgaard H, Hermansen MN, Loland L, Halkjaer LB, Buchvald F: Intermittent Inhaled Corticosteroids in Infants with Episodic Wheezing. The New England Journal of Medicine. 2006, 354: 1998-2005. 10.1056/NEJMoa054692.CrossRefPubMed Bisgaard H, Hermansen MN, Loland L, Halkjaer LB, Buchvald F: Intermittent Inhaled Corticosteroids in Infants with Episodic Wheezing. The New England Journal of Medicine. 2006, 354: 1998-2005. 10.1056/NEJMoa054692.CrossRefPubMed
56.
go back to reference Guilbert TW, Morgan WJ, Zeiger RS, Mauger DT, Boehmer SJ, Szefler SJ, et al: Long-Term Inhaled Corticosteroids in Preschool Children at High Risk for Asthma. The New England Journal of Medicine. 2006, 354: 1985-1997. 10.1056/NEJMoa051378.CrossRefPubMed Guilbert TW, Morgan WJ, Zeiger RS, Mauger DT, Boehmer SJ, Szefler SJ, et al: Long-Term Inhaled Corticosteroids in Preschool Children at High Risk for Asthma. The New England Journal of Medicine. 2006, 354: 1985-1997. 10.1056/NEJMoa051378.CrossRefPubMed
Metadata
Title
Prediction and treatment of asthma in preschool children at risk: study design and baseline data of a prospective cohort study in general practice (ARCADE)
Authors
Karina E van Wonderen
Lonneke B van der Mark
Jacob Mohrs
Ronald B Geskus
Willem M van der Wal
Wim MC van Aalderen
Patrick JE Bindels
Gerben ter Riet
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2009
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/1471-2466-9-13

Other articles of this Issue 1/2009

BMC Pulmonary Medicine 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.